# OnCo record lms-04 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/lms-04/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "lms-04", "NCT02997358" ;
  schema:name "LMS-04"@en ;
  schema:description "In leiomyosarcoma, adding trabectedin to doxorubicin roughly doubled the time the disease stayed controlled, the first randomised first-line gain in this sarcoma in decades."@en ;
  schema:url <https://onco.cc/trials/lms-04/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02997358>, <https://doi.org/10.1016/S1470-2045(22)00380-1> ;
  onco:status "positive" ;
  onco:tag "subtype-page" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/leiomyosarcoma/>, <https://onco.cc/cancers/uterine-sarcoma/>, <https://onco.cc/cancers/extremity-soft-tissue-sarcoma/>, <https://onco.cc/cancers/retroperitoneal-sarcoma/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/trabectedin/> .